Bibliography

1. Dyer O. Covid-19: Delta infections threaten herd immunity vaccine strategy. BMJ. 2021 Aug 2;374:n1933.
2. Bhogireddy R, Krishnamurthy V, Jabaris S SL, Pullaiah CP, Manohar S. Is Mucormycosis an inevitable complication of Covid-19 in India? Braz J Infect Dis. 2021 May 1;25(3):101597.
3. Rocha ICN, Hasan MM, Goyal S, Patel T, Jain S, Ghosh A, et al. COVID‐19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Trop Med Int Health. 2021 Sep;26(9):1016–8.
4. Honavar SG. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19. Indian J Ophthalmol. 2021 Jun;69(6):1361–5.
5. MohanaSundaram A, Thukani Sathanantham S, Chinchole V, Patil B, Velayutham R. Fostering a deeper understanding of COVID-19-associated mucormycosis – A commentary on “The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum” (Int. J. Surg. 2021:106031). Int J Surg Lond Engl. 2021 Oct;94:106110.
6. Frank GS, Smith JM, Davies BW, Mirsky DM, Hink EM, Durairaj VD. Ophthalmic manifestations and outcomes after cavernous sinus thrombosis in children. J Am Assoc Pediatr Ophthalmol Strabismus. 2015 Aug 1;19(4):358–62.
7. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J. 1992 Oct 17;305(6859):913–20.
8. Sahoo NK, Kulkarni V, Bhandari AK, Kumar A. Mucormycosis of the Frontal Sinus: A Rare Case Report and Review. Ann Maxillofac Surg. 2017;7(1):120–3.
9. Kaufman RS, Stone G. Osteomyelitis of frontal bone secondary to mucormycosis. N Y State J Med. 1973 Jun 1;73(11):1325–8.
10. Chan L-L, Singh S, Jones D, Jr EMD, Ginsberg LE. Imaging of Mucormycosis Skull Base Osteomyelitis. Am J Neuroradiol. 2000 May 1;21(5):828–31.
11. Verma A, Singh V, Jindal N, Yadav S. Necrosis of maxilla, nasal, and frontal bone secondary to extensive rhino-cerebral mucormycosis. Natl J Maxillofac Surg. 2013;4(2):249–51.
12. Hosseini SMS, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg. 2005 Nov;262(11):932–8.
13. Bell RB. Management of frontal sinus fractures. Oral Maxillofac Surg Clin N Am. 2009 May;21(2):227–42.
14. Gillespie MB, O’Malley BW. An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol Clin North Am. 2000 Apr;33(2):323–34.
15. Pakdel F, Ahmadikia K, Salehi M, Tabari A, Jafari R, Mehrparvar G, et al. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicenter study from Iran. Mycoses. 2021 Jun 7;
16. Scheckenbach K, Cornely O, Hoffmann TK, Engers R, Bier H, Chaker A, et al. Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis. Auris Nasus Larynx. 2010 Jun;37(3):322–8.
17. Anaissie EJ, Shikhani AH. Rhinocerebral mucormycosis with internal carotid occlusion: report of two cases and review of the literature. The Laryngoscope. 1985 Sep;95(9 Pt 1):1107–13.
18. Camara-Lemarroy CR, González-Moreno EI, Rodríguez-Gutiérrez R, Rendón-Ramírez EJ, Ayala-Cortés AS, Fraga-Hernández ML, et al. Clinical Features and Outcome of Mucormycosis. Interdiscip Perspect Infect Dis. 2014 Aug 20;2014:e562610.
19. Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis Off Publ Infect Dis Soc Am. 2007 May 15;44(10):1289–97.
20. Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP. Therapy of Mucormycosis. J Fungi. 2018 Sep;4(3):90.
21. Hoenigl M, Gangneux J-P, Segal E, Alanio A, Chakrabarti A, Chen SC-A, et al. Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together. Mycoses. 2018 Nov;61(11):885–94.